Pfizer: 40 years of TBE production in Austria

Name: _pk_id Used for : Is used to store an unique ID for each user Duration : 13 Months
Name: &nbsp;_pk_ses, _pk_cvar, _pkhsr Used for :&nbsp;Session cookies that store temporary data Duration :&nbsp;30 minutes
Name: mtm_consent Used for : Stores cookie preferences Duration : 30 years

The active ingredients of some 10 million doses of the TBE vaccine are currentlyproduced in Austria annually. The vaccine protects against all known TBE-virus subtypes and has been developed by virologists at the University of Vienna 40 years ago.

Sorry, this entry is only available in German!

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.

Pfizer: 40 years of TBE production in Austria

ABOL – Austrian Barcode of Life: eine Mission für Biodiversität in Österreich

vetmeduni Vienna: New insights and pioneering work in targeted therapy against blood cancer

Uni Vienna: How soil microbes survive in harsh desert environments